サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629159

自動無効化シリンジの世界市場：製品タイプ別、症状別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）

Auto Disable Syringes Market, By Product Type, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 288 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
自動無効化シリンジの世界市場：製品タイプ別、症状別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測（2024年～2032年）
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 288 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

世界の自動無効化シリンジの市場規模は、2023年に235億6,054万米ドルと評価され、2024年～2032年にCAGR11.50%で拡大すると予測されます。

自動無効化シリンジ市場：市場力学

針刺し損傷や交差感染の増加が市場に大きな影響を与えると予測

自動無効化シリンジは、再使用を防止するように設計されているため、HIV、B型肝炎、C型肝炎などの感染症のトランスミッションのリスクを低減することができます。安全な注射の実践の重要性については、医療提供者や患者の間で認識が高まっています。看護師における針刺しや鋭利な傷害の有病率は非常に高く（95.36％）、約半数が5回以上の傷害を受けていました。米国国立衛生研究所によると、女性看護師と救急部門に所属する看護師は、針刺しや鋭利な傷害を受ける可能性が高くなっていました（それぞれp=0.018と0.021）。さらに、費用対効果が高く環境に優しい材料を含むシリンジ製造の革新は、市場に成長機会をもたらす可能性があります。しかし、環境への懸念は市場の成長を制限する可能性があります。

自動無効化シリンジ市場：主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024年～2032年）に約11.50%のCAGRで毎年成長すると予測されています。

用途別セグメントでは、ワクチン接種が2023年の主要セグメントでした。

エンドユーザー別では、病院が2023年の主要セグメントでした。

地域別では、北米が2023年の主要収益源でした。

自動無効化シリンジ市：セグメンテーション分析：

自動無効化シリンジの世界市場は、製品タイプ、症状、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプ別に2つのカテゴリー：リトラクタブル、非リトラクタブル、その他に分けられます。各カテゴリーには、安全性を向上させ、シリンジの再使用の可能性を排除するために設計された異なる技術が含まれています。リトラクタブル無効化シリンジは、針刺し損傷や交差汚染のリスクを大幅に低減する能力により、病院、診療所、予防接種の取り組みで広く利用されています。非リトラクタブル無効化シリンジは、通常プランジャーをロックするかバレルを破損することにより、1回の使用でシリンジを使用不能にする機構を備えています。

市場は症状別に2つのセグメント：感染症と炎症性疾患/自己免疫疾患に分けられます。この分類は、ワクチン接種への取り組みや慢性疾患の管理など、主要な医療上の優先事項と市場の整合性を反映するものであり、極めて重要です。肝炎、HIV、結核、COVID-19などの疾患に対するワクチン接種の取り組みが重視されるようになり、安全設計シリンジの需要が大幅に高まっています。先進地域では医療制度が発達しているため市場開拓が見られる一方、新興国市場では自己免疫疾患の流行が増加しています。両分野とも、注射の安全性への注目の高まり、医療支出の増加、注射針の再使用に関連するリスクを低減する必要性によって推進されています。

市場は用途別に3つの主要カテゴリー：採血、ドラッグデリバリー、ワクチン接種に分けられます。ワクチン接種は、市場成長の主要な起爆剤となっています。自動無効化シリンジは、再使用の可能性を排除するよう特別に設計されており、ワクチン投与の安全性を高め、交差汚染や感染伝播の可能性を減少させます。この特性により、感染症対策を目的とした公衆衛生戦略において極めて重要な要素となっています。特に、世界保健機関（WHO）やGavi（ワクチン同盟）などの団体が実施する大規模なワクチン接種活動では、自動無効化シリンジの導入が重要です。

市場はエンドユーザー別に、病院、診療所、診断検査室、外来手術センター、その他の4つに分類されます。病院はこの市場で主導的な役割を果たしています。治療やワクチン接種の主要施設として機能する病院は、注射針の再使用や汚染に関連するリスクを最小限に抑えるために不可欠な自動無効化シリンジの主要消費者です。医療サービスの主要な提供者である病院は、さまざまな医療目的での自動無効化シリンジ採用に役立っています。

自動無効化シリンジ市場：地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカと地理的に広範囲に及んでいます。これらの地域は、事業活動に貢献している国に基づいてさらに区分されます。北米が市場をリードしているのは、主に医療支出の増加によるものです。医療システムの強化に向けた資源配分の増加は、自動無効化シリンジのような先進医療機器の普及を促進しています。メディケア・メディケイド・サービスセンターによると、米国の医療支出は2022年に4.1％増加し、総額4兆5,000億米ドル、国民1人当たり1万3,493米ドルとなりました。医療費は国内総生産の17.3％を占めます。欧州は、予防接種需要の高まりにより、市場成長率第2位の地域となっています。

自動無効化シリンジ市場：競合情勢：

自動無効化シリンジ市場は、安全な注射方法に対する世界の需要の高まり、規制要件、技術革新に後押しされた激しい競合が特徴です。企業は、安全性を向上させるため、リトラクタブル注射針や耐タンパー設計など、洗練された機能の開発に注力しています。先進地域では著名な世界企業が市場をリードし、高品質で技術的に優れたシリンジを提供しています。メーカーはまた、製品の安全基準を維持しながら生産コストを下げるために、規模の経済を活用しています。

目次

第1章 自動無効化シリンジ市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 自動無効化シリンジの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 自動無効化シリンジ業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 自動無効化シリンジ市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 自動無効化シリンジ市場情勢

  • 自動無効化シリンジ市場シェア分析：2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 自動無効化シリンジ市場：製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • リトラクタブル
    • 非リトラクタブル
    • その他

第8章 自動無効化シリンジ市場：症状別

  • 概要
    • 症状別のセグメントシェア分析
    • 感染症
    • 炎症性疾患/自己免疫疾患

第9章 自動無効化シリンジ市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 採血
    • ドラッグデリバリー
    • 予防接種

第10章 自動無効化シリンジ市場：エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 病院
    • 診療所
    • 診断検査室
    • 外来手術センター
    • その他

第11章 自動無効化シリンジ市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：自動無効化シリンジ業界

  • 競合ダッシュボード
    • 競合ベンチマーキング
    • 競合ポジショニング
  • 企業プロファイル
    • AdvaCare Pharma
    • Al Shifa Medical Products Co.
    • Apple Syringe
    • Becton Dickinson &Company
    • Duopross Meditech Corp.
    • Hindustan Syringes &Medical Devices Ltd
    • Hunan Pingan Medical Device Technology Co., Ltd.
    • Injecto A/S
    • Iscon Surgicals Ltd.
    • JMI SYRINGES &MEDICAL DEVICES LTD.
    • Merck KGaA
    • PT Oneject Indonesia
    • Retractable Technologies, Inc.
    • Sanavita Pharmaceuticals GmbH
    • Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • Shanghai Kohope Medical Devices Co., Ltd.
    • Shenzhen Medis Medical
    • Terumo Corporation
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4358

REPORT HIGHLIGHT

The Auto-Disable Syringes Market was valued at USD 23,560.54 million in 2023 and expanded at a CAGR of 11.50% from 2024 to 2032.

Auto-disable syringe mechanisms are engineered to eliminate the possibility of syringe reuse. These devices are predominantly utilized in immunization initiatives, especially in developing nations, to guarantee the secure disposal of syringes and mitigate the spread of bloodborne pathogens. Typically, auto-disable syringes incorporate a mechanism that engages after a single application. They are frequently employed in large-scale vaccination efforts, where rapid immunization of numerous individuals is essential. Following their use, the auto-disable function ensures that the syringes are rendered unusable, encouraging safe disposal methods.

Auto Disable Syringes Market- Market Dynamics

The increasing prevalence of needle stick injuries and cross infections is anticipated to influence the market significantly

Auto-disable syringes are designed to prevent reuse, thereby reducing the risk of transmission of infectious diseases such as HIV, hepatitis B, and hepatitis C, which are often spread through contaminated or reused needles. There is growing awareness among healthcare providers and patients about the importance of safe injection practices. The prevalence of needle sticks and sharp injuries among nurses was very high (95.36%), and around half were injured more than five times. Female nurses and those in an emergency department were more likely to be subjected to needle sticks and sharp injuries (p = 0.018 and 0.021, respectively), According to the National Institutes of Health. Furthermore, Innovations in syringe manufacturing, including cost-effective and eco-friendly materials may provide growth opportunities for the market. However, Environmental Concerns may restrict the market growth.

Auto Disable Syringes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.50% over the forecast period (2024-2032)

Based on Application segmentation, Vaccination was the leading segment in 2023

Based on End-User segmentation, Hospitals was the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Auto Disable Syringes Market- Segmentation Analysis:

The Global Auto Disable Syringes Market is segmented based on Product Type, Indication, Application, End-User, and Region.

The market is divided into two specific categories based on product type: Retractable, Non-Retractable, and others. Each category encompasses different technologies designed to improve safety and eliminate the possibility of syringe reuse. Retractable Disable Syringes are favored for their ability to significantly lower the risk of needle stick injuries and cross-contamination, making them widely utilized in hospitals, clinics, and vaccination initiatives. Non-retractable disable Syringes feature a mechanism that renders the syringe unusable after a single use, typically by locking the plunger or breaking the barrel.

The market is divided into two segments based on Indication: Infectious Diseases and Inflammatory/Auto-Immune Diseases. This classification is crucial as it reflects the market's alignment with key medical priorities, including vaccination efforts and the management of chronic conditions. The heightened emphasis on vaccination initiatives for diseases such as hepatitis, HIV, tuberculosis, and COVID-19 significantly enhances the demand for safety-engineered syringes. Growth is observed in developed regions due to their advanced healthcare systems while emerging markets are experiencing an increase in auto-immune disease prevalence. Both segments are propelled by a growing focus on injection safety, rising healthcare expenditures, and the necessity to reduce risks linked to needle reuse.

The market is divided into three main categories based on application: Blood Collection, Drug Delivery, and Vaccination. Vaccination serves as the key catalyst for market growth. Auto-disable syringes are specifically designed to eliminate the possibility of reuse, thereby enhancing the safety of vaccine administration and decreasing the likelihood of cross-contamination and infection transmission. This characteristic makes them a crucial component in public health strategies aimed at combating infectious diseases. The implementation of auto-disable syringes is especially important in large-scale vaccination efforts conducted by entities such as the World Health Organization (WHO) and Gavi, the Vaccine Alliance.

The market is divided into four main categories based on the End-User: Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others. Hospitals occupy a leading role in this market. Serving as the primary facilities for treatment and vaccination, hospitals are major consumers of auto-disable syringes, which are vital for minimizing the risks linked to needle reuse and contamination. As key providers of healthcare services, hospitals are instrumental in the adoption of auto-disable syringes for a range of medical purposes.

Auto Disable Syringes Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads the market, primarily due to an increase in healthcare expenditures. The growing allocation of resources towards enhancing healthcare systems has facilitated the widespread adoption of advanced medical devices, such as auto-disable syringes. According to the Centers for Medicare and Medicaid Services, healthcare spending in the United States rose by 4.1 percent in 2022, totaling USD 4.5 trillion, or USD 13,493 per capita. Health expenditures represented 17.3 percent of the nation's Gross Domestic Product. Europe ranks as the second-largest region for market growth, driven by a rising demand for immunization coverage.

Auto Disable Syringes Market- Competitive Landscape:

The market for auto-disable syringes is characterized by intense competition, fueled by rising global demand for secure injection methods, regulatory requirements, and innovations in technology. Firms are focusing on the development of sophisticated features, including retractable needles and tamper-resistant designs, to improve safety. Prominent global corporations lead the market in developed regions, offering high-quality and technologically superior syringes. Manufacturers are also capitalizing on economies of scale to lower production costs while upholding safety standards for their products.

Recent Developments:

On September 18, 2024, BD (Becton, Dickinson, and Company), a prominent global medical technology firm, declared the commercial launch of the BD Neopak XtraFlow Glass Prefillable Syringe. Additionally, the company announced an expansion in capacity for the BD Neopak Glass Prefillable Syringe platform to meet the increasing demand in the biologic therapies market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTO DISABLE SYRINGES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AdvaCare Pharma
  • Al Shifa Medical Products Co.
  • Apple Syringe
  • Becton Dickinson & Company
  • Duopross Meditech Corp.
  • Hindustan Syringes & Medical Devices Ltd
  • Hunan Pingan Medical Device Technology Co., Ltd.
  • Injecto A/S
  • Iscon Surgicals Ltd.
  • JMI SYRINGES & MEDICAL DEVICES LTD.
  • Merck KGaA
  • PT Oneject Indonesia
  • Retractable Technologies, Inc.
  • Sanavita Pharmaceuticals GmbH
  • Shandong Zhushi Pharmaceutical Group Co., Ltd.
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Shenzhen Medis Medical
  • Terumo Corporation
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Retractable
  • Non-Retractable
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Inflammatory/Auto-Immune Diseases

GLOBAL AUTO DISABLE SYRINGES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Blood Collection
  • Drug Delivery
  • Vaccination

GLOBAL AUTO DISABLE SYRINGES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Auto Disable Syringes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Auto Disable Syringes Market Snippet by Product Type
    • 2.1.2. Auto Disable Syringes Market Snippet by Indication
    • 2.1.3. Auto Disable Syringes Market Snippet by Application
    • 2.1.4. Auto Disable Syringes Market Snippet by End-User
    • 2.1.5. Auto Disable Syringes Market Snippet by Country
    • 2.1.6. Auto Disable Syringes Market Snippet by Region
  • 2.2. Competitive Insights

3. Auto Disable Syringes Key Market Trends

  • 3.1. Auto Disable Syringes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Auto Disable Syringes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Auto Disable Syringes Market Opportunities
  • 3.4. Auto Disable Syringes Market Future Trends

4. Auto Disable Syringes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Auto Disable Syringes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Auto Disable Syringes Market Landscape

  • 6.1. Auto Disable Syringes Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Auto Disable Syringes Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Retractable
    • 7.1.3. Non-Retractable
    • 7.1.4. Others

8. Auto Disable Syringes Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Inflammatory/Auto-Immune Diseases

9. Auto Disable Syringes Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Blood Collection
    • 9.1.3. Drug Delivery
    • 9.1.4. Vaccination

10. Auto Disable Syringes Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Diagnostic Laboratories
    • 10.1.5. Ambulatory Surgical Centers
    • 10.1.6. Others

11. Auto Disable Syringes Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Auto Disable Syringes Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Auto Disable Syringes Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Auto Disable Syringes Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Auto Disable Syringes Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Auto Disable Syringes Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Auto Disable Syringes Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AdvaCare Pharma
    • 12.2.2. Al Shifa Medical Products Co.
    • 12.2.3. Apple Syringe
    • 12.2.4. Becton Dickinson & Company
    • 12.2.5. Duopross Meditech Corp.
    • 12.2.6. Hindustan Syringes & Medical Devices Ltd
    • 12.2.7. Hunan Pingan Medical Device Technology Co., Ltd.
    • 12.2.8. Injecto A/S
    • 12.2.9. Iscon Surgicals Ltd.
    • 12.2.10. JMI SYRINGES & MEDICAL DEVICES LTD.
    • 12.2.11. Merck KGaA
    • 12.2.12. PT Oneject Indonesia
    • 12.2.13. Retractable Technologies, Inc.
    • 12.2.14. Sanavita Pharmaceuticals GmbH
    • 12.2.15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • 12.2.16. Shanghai Kohope Medical Devices Co., Ltd.
    • 12.2.17. Shenzhen Medis Medical
    • 12.2.18. Terumo Corporation
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us